No, this won’t be a serialized novel. Instead, there will be new information about a drugmaker’s internal investigation into unapproved detailing materials and improper funding of continuing medical education. The source: an employee who witnessed the alleged activities first-hand, provided documentation and now claims retaliation.

The first of a few such installments runs tomorrow. At a time when there is growing controversy over pharma’s behind-the-scenes promotional practices, this episode is a reminder of the tension that can exist among pharma employees as they struggle to generate profits, keep their jobs and, in some cases, try to put patients first.

So stop by in the morning….